Central Serous Chorioretinopathy, Diabetic Retinopathy, Epiretinal Membranes, Macular Degeneration, Macular Disorders, Macular Holes, Macular Puckers, Ocular Trauma, Ophthalmology, Retinal Detachment, Retinal Specialist, Retinal Surgery, Retinal Vascular Disease, Retinal Vein Occlusion, Retinal Vessel Occlusion, Surgical and Medical Diseases of the Retina, Vitreoretinal Diseases and Surgery Service ...read more
Central Serous Chorioretiniopathy ; Endophthalmitis; Microsurgical Instrument Development; Imaging; Optical Coherence Tomography Angiography; Macular Degeneration (Age-Related); Macular Telangiectasia; Retinal Vessel Occlusion ...read more
Mark Breazzano, M.D., is a retina specialist and accomplished surgeon seeing patients at the Wilmer Eye Institute’s locations in Frederick and Baltimore, Maryland. He specializes in the diagnosis and treatment of medical and surgical vitreoretinal diseases including macular degeneration, diabetic retinopathy, retinal detachment, epiretinal membranes, macular holes and more.
Dr. Breazzano is an award-winning researcher and surgeon who holds a patent and has authored more than 80 publications including peer-reviewed papers, book chapters and abstracts that span a diverse selection of vitreoretinal diseases. His research has been featured in WebMD, Newsday, Medscape, American Council on Science and Health, and American Academy of Ophthalmology’s EyeNet Magazine.
His research is focused on accurate determination of endophthalmitis in the setting of Candida bloodstream infections and optimizing medical and surgical management for blinding diseases.
Learn more about clinical trials at Johns Hopkins Medicine.
Another Tragedy Tied to Opioids: Eye Disease - U.S. News & World Report (Nov. 2020)
Breazzano Brings Energy, Innovative Thinking to Wilmer - Johns Hopkins Medicine (Aug. 2020)
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Comments